|
sars-cov-2 |
24 |
|
covid-19 |
12 |
|
pathogenicity |
8 |
|
transmission |
8 |
|
bronchial tissue |
7 |
|
china |
7 |
|
hong kong |
7 |
|
nasal tissue |
7 |
|
omicron ba.2 |
7 |
|
sars |
7 |
|
air travel-related outbreak |
6 |
|
coronavirus disease |
6 |
|
disease transmission control |
6 |
|
genomic diversity |
6 |
|
genomic epidemiology |
6 |
|
surveillance |
6 |
|
variant |
6 |
|
wastewater genome sequencing |
6 |
|
wastewater-based epidemiology |
6 |
|
whole genome sequencing |
6 |
|
mutations |
5 |
|
omicron |
5 |
|
omicron variants |
5 |
|
rt-qpcr |
5 |
|
sequencing |
5 |
|
syrian hamsters |
5 |
|
wastewater surveillance |
5 |
|
2019 ncov whu01 |
4 |
|
2019 novel coronavirus disease |
4 |
|
adult |
4 |
|
algorithm |
4 |
|
amplicon |
4 |
|
antigenic cartography |
4 |
|
betacov/nepal/61/2020 |
4 |
|
bivalent rna vaccine |
4 |
|
codon usage analysis |
4 |
|
coronavirus |
4 |
|
heterosubtypic immunity |
4 |
|
immune evasion |
4 |
|
infection-naïve |
4 |
|
influenza virus |
4 |
|
mouse-adaptation |
4 |
|
neutralization |
4 |
|
next-generation sequencing |
4 |
|
omicron subvariant |
4 |
|
universal vaccines |
4 |
|
wca |
4 |
|
co-infection |
3 |
|
human respiratory viruses |
3 |
|
rt-ddpcr |
3 |
|
boosted regression trees |
2 |
|
codon usage |
2 |
|
coronaviruses |
2 |
|
dengue fever |
2 |
|
dinucleotide usage |
2 |
|
evolution |
2 |
|
influenza |
2 |
|
influenza a virus |
2 |
|
mathematical model |
2 |
|
meteorological effects |
2 |
|
norovirus |
2 |
|
outbreak |
2 |
|
water disinfection |
2 |
|
cardiovascular disease |
1 |
|
causal inference |
1 |
|
cohort |
1 |
|
greenness |
1 |
|
lifestyles interaction |
1 |
